ResMed Inc. (0KW4.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 37.6B |
| Enterprise Value | 37.27B |
| P/E Ratio | 18.16 |
| PEG Ratio | 1.14 |
| Price/Sales Ratio | 4.94 |
| Price/Book Ratio | 4.25 |
| Enterprise/Revenue | 4.79 |
| Enterprise/EBITDA | 12.13 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.27 |
| Operating Margin | 0.34 |
AD
Management Effectiveness
| Return On Assets | 0.17 |
| Return On Equity | 0.24 |
Income Statement
| Revenue | 5.15B |
| Revenue/Share | 37.81 |
| Gross Profit | 3.05B |
| EBITDA | 1.91B |
| Net Income | 1.4B |
| Diluted EPS | 9.51 |
Balance Sheet
| Total Cash | 1.66B |
| Total Cash/Share | 11.37 |
| Total Debt | 843.17M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 3.01 |
| Book Value Per Share | 44.32 |
Price History
| 52-Week Change | -24.71 |
| 52-Week High | 240 |
| 52-Week Low | 132.67 |
| Moving Average 50 Days | 181.11 |
| Moving Average 200 Days | 176.89 |
Statistics
| Average Volume | 2,991 |
| Shares Outstanding | 142.5M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.4 |
| Trailing Annual Dividend Yield | 1.27 |
| Payout Ratio | 0.22 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
